相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Comparison of the Early Fungicidal Activity of High-Dose Fluconazole, Voriconazole, and Flucytosine as Second-Line Drugs Given in Combination With Amphotericin B for the Treatment of HIV-Associated Cryptococcal Meningitis
Angela Loyse et al.
CLINICAL INFECTIOUS DISEASES (2012)
The Effect of Therapeutic Drug Monitoring on Safety and Efficacy of Voriconazole in Invasive Fungal Infections: A Randomized Controlled Trial
Wan Beom Park et al.
CLINICAL INFECTIOUS DISEASES (2012)
Challenging Recommended Oral and Intravenous Voriconazole Doses for Improved Efficacy and Safety: Population Pharmacokinetics-Based Analysis of Adult Patients With Invasive Fungal Infections
Andres Pascual et al.
CLINICAL INFECTIOUS DISEASES (2012)
Pre-emptive diagnosis and treatment of fungal infectionsuevaluation of a single-centre policy
T. Schneider et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
An observational efficacy and safety analysis of the treatment of acute invasive aspergillosis using voriconazole
F. Jacobs et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2012)
Universal antifungal therapy is not needed in persistent febrile neutropenia: a tailored diagnostic and therapeutic approach
Manuela Aguilar-Guisado et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Successful Treatment of Disseminated Cryptococcal Infection in a Pediatric Acute Lymphoblastic Leukemia Patient During Induction
Jessica L. Heath et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2012)
Successful treatment of Trichosporon fungemia in a patient with refractory acute myeloid leukemia using voriconazole combined with liposomal amphotericin B
K. Hosokawa et al.
TRANSPLANT INFECTIOUS DISEASE (2012)
Efficacy of Caspofungin in a Juvenile Mouse Model of Central Nervous System Candidiasis
Amy M. Flattery et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Phase II Dose Escalation Study of Caspofungin for Invasive Aspergillosis
O. A. Cornely et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Observational Study of the Clinical Efficacy of Voriconazole and Its Relationship to Plasma Concentrations in Patients
Peter F. Troke et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation
David I. Marks et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
The Diagnostic Value of Halo and Reversed Halo Signs for Invasive Mold Infections in Compromised Hosts
Sarah P. Georgiadou et al.
CLINICAL INFECTIOUS DISEASES (2011)
Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007
A. Skiada et al.
CLINICAL MICROBIOLOGY AND INFECTION (2011)
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours
M. S. Aapro et al.
EUROPEAN JOURNAL OF CANCER (2011)
The efficacy of voriconazole in the treatment of 192 fungal central nervous system infections: a retrospective analysis
S. Schwartz et al.
INFECTION (2011)
Diagnosis and therapy of Candida infections: joint recommendations of the German Speaking Mycological Society and the Paul-Ehrlich-Society for Chemotherapy
Markus Ruhnke et al.
MYCOSES (2011)
Infection and colonisation due to Scedosporium in Northern Spain. An in vitro antifungal susceptibility and molecular epidemiology study of 60 isolates
M. Lackner et al.
MYCOSES (2011)
International Retrospective Analysis of 73 Cases of Invasive Fusariosis Treated with Voriconazole
Olivier Lortholary et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation
John R. Wingard et al.
BLOOD (2010)
Caspofungin Use in Daily Clinical Practice for Treatment of Invasive Aspergillosis: Results of a Prospective Observational Registry
Johan Maertens et al.
BMC INFECTIOUS DISEASES (2010)
Caspofungin first-line therapy for invasive aspergillosis in allogeneic hematopoietic stem cell transplant patients: an European Organisation for Research and Treatment of Cancer study
R. Herbrecht et al.
BONE MARROW TRANSPLANTATION (2010)
Comparison of 2 Doses of Liposomal Amphotericin B and Conventional Amphotericin B Deoxycholate for Treatment of AIDS-Associated Acute Cryptococcal Meningitis: A Randomized, Double-Blind Clinical Trial of Efficacy and Safety
Richard J. Hamill et al.
CLINICAL INFECTIOUS DISEASES (2010)
Combination Flucytosine and High-Dose Fluconazole Compared with Fluconazole Monotherapy for the Treatment of Cryptococcal Meningitis: A Randomized Trial in Malawi
Jesse C. Nussbaum et al.
CLINICAL INFECTIOUS DISEASES (2010)
Factors Associated with Mortality in Transplant Patients with Invasive Aspergillosis
John W. Baddley et al.
CLINICAL INFECTIOUS DISEASES (2010)
Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
John R. Perfect et al.
CLINICAL INFECTIOUS DISEASES (2010)
Fatal Trichosporon fungemia in patients with hematologic malignancies
Kei Suzuki et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study
Livio Pagano et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Forty-one recent cases of invasive zygomycosis from a global clinical registry
M. J. G. T. Rueping et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Invasive fusariosis in patients with hematologic malignancies at a cancer center: 1998-2009
Marcela Campo et al.
JOURNAL OF INFECTION (2010)
Primary treatment of zygomycosis with liposomal amphotericin B: analysis of 28 cases
Shmuel Shoham et al.
MEDICAL MYCOLOGY (2010)
A prospective randomized controlled trial comparing PCR-based and empirical treatment with liposomal amphotericin Bin patients after allo-SCT
H. Hebart et al.
BONE MARROW TRANSPLANTATION (2009)
Invasive Trichosporonosis Caused by Trichosporon asahii and Other Unusual Trichosporon Species at a Medical Center in Taiwan
Sheng-Yuan Ruan et al.
CLINICAL INFECTIOUS DISEASES (2009)
A Multicenter, Double-Blind Trial of a High-Dose Caspofungin Treatment Regimen versus a Standard Caspofungin Treatment Regimen for Adult Patients with Invasive Candidiasis
Robert F. Betts et al.
CLINICAL INFECTIOUS DISEASES (2009)
Empirical versus Preemptive Antifungal Therapy for High-Risk, Febrile, Neutropenic Patients: A Randomized, Controlled Trial
Catherine Cordonnier et al.
CLINICAL INFECTIOUS DISEASES (2009)
Epidemiology and Outcome of Invasive Fungal Infection in Adult Hematopoietic Stem Cell Transplant Recipients: Analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance Registry
D. Neofytos et al.
CLINICAL INFECTIOUS DISEASES (2009)
Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America
Peter G. Pappas et al.
CLINICAL INFECTIOUS DISEASES (2009)
Monitoring trough concentration of voriconazole is important to ensure successful antifungal therapy and to avoid hepatic damage in patients with hematological disorders
Koki Ueda et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2009)
An EORTC Phase II study of caspofungin as first-line therapy of invasive aspergillosis in haematological patients
C. Viscoli et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Cryptococcus neoformans Fatal Sepsis in a Chronic Lymphocytic Leukemia Patient Treated with Alemtuzumab: Case Report and Review of the Literature
M. Bassetti et al.
JOURNAL OF CHEMOTHERAPY (2009)
Voriconazole for Cryptococcal Meningitis in Children with Leukemia or Receiving Allogeneic Hemopoietic Stem Cell Transplant
R. Bandettini et al.
JOURNAL OF CHEMOTHERAPY (2009)
Epidemiology and outcome of Scedosporium prolificans infection, a review of 162 cases
Juan Luis Rodriguez-Tudela et al.
MEDICAL MYCOLOGY (2009)
A review of German Scedosporium prolificans cases from 1993 to 2007
K. Tintelnot et al.
MEDICAL MYCOLOGY (2009)
Scedosporium prolificans: an emerging pathogen in France?
Frederic Grenouillet et al.
MEDICAL MYCOLOGY (2009)
MEDICAL PROGRESS Aspergillosis
Brahm H. Segal
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Invasive zygomycosis in India: experience in a tertiary care hospital
A. Chakrabarti et al.
POSTGRADUATE MEDICAL JOURNAL (2009)
Therapeutic Drug Monitoring of Antifungals: Pharmacokinetic and Pharmacodynamic Considerations
Jeannina Smith et al.
THERAPEUTIC DRUG MONITORING (2009)
Micafungin alone or in combination with other systemic antifungal therapies in hematopoietic stem cell transplant recipients with invasive aspergillosis
D. P. Kontoyiannis et al.
TRANSPLANT INFECTIOUS DISEASE (2009)
Central venous catheter-related infections in hematology and oncology
Hans-Heinrich Wolf et al.
ANNALS OF HEMATOLOGY (2008)
Randomized phase III study of granulocyte transfusions in neutropenic patients
M. G. Seidel et al.
BONE MARROW TRANSPLANTATION (2008)
Amphotericin B lipid complex versus liposomal amphotericin B monotherapy for invasive aspergillosis in patients with hematologic malignancy
Ray Y. Hachem et al.
CANCER (2008)
Adjuvant corticosteroid therapy for chronic disseminated candidiasis
Faezeh Legrand et al.
CLINICAL INFECTIOUS DISEASES (2008)
Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes
Andres Pascual et al.
CLINICAL INFECTIOUS DISEASES (2008)
Treatment of aspergillosis: Clinical practice guidelines of the infectious diseases society of America
Thomas J. Walsh et al.
CLINICAL INFECTIOUS DISEASES (2008)
Factors associated with overall and attributable mortality in invasive aspergillosis
Yasmine Nivoix et al.
CLINICAL INFECTIOUS DISEASES (2008)
High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: A randomized trial
Tihana Bicanic et al.
CLINICAL INFECTIOUS DISEASES (2008)
Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses study group and European Organization for Research and Treatment of Cancer consensus criteria
Brahm H. Segal et al.
CLINICAL INFECTIOUS DISEASES (2008)
Reversed halo sign in invasive pulmonary fungal infections
Hisham Wahba et al.
CLINICAL INFECTIOUS DISEASES (2008)
Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis
Caitlin Reed et al.
CLINICAL INFECTIOUS DISEASES (2008)
Infections caused by Scedosporium spp.
Karoll J. Cortez et al.
CLINICAL MICROBIOLOGY REVIEWS (2008)
Treatment-related risk factors for hospital mortality in Candida bloodstream infections
Andrew J. Labelle et al.
CRITICAL CARE MEDICINE (2008)
Brain stem candidiasis mimicking cerebellopontine angle tumor
Xin-yu Hong et al.
SURGICAL NEUROLOGY (2008)
Surgical treatment of pulmonary aspergillosis/mycosis in immunocompromised patients
B. C. Danner et al.
Interactive Cardiovascular and Thoracic Surgery (2008)
Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin
I. I. Raad et al.
LEUKEMIA (2008)
Breakthrough Trichosporon asahii fungemia in neutropenic patient with acute leukemia while receiving caspofungin
G. Bayramoglu et al.
INFECTION (2008)
Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies -: A randomized pilot study (Combistrat trial)
Denis Caillot et al.
CANCER (2007)
Intravascular catheter-related infections: advances in diagnosis, prevention, and management
Issam Raad et al.
LANCET INFECTIOUS DISEASES (2007)
Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis
Peter G. Pappas et al.
CLINICAL INFECTIOUS DISEASES (2007)
Caspofungin for the treatment of less common forms of invasive candidiasis
Oliver A. Cornely et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Treatment of invasive Candida and invasive Aspergillus infections in adult haematological patients
Raoul Herbrecht et al.
EJC SUPPLEMENTS (2007)
Anidulafungin versus fluconazole for invasive candidiasis
Annette C. Reboli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Liposomal amphotericin B as initial therapy for invasive mold infection: A randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial)
Oliver A. Cornely et al.
CLINICAL INFECTIOUS DISEASES (2007)
Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial
Ernst-Ruediger Kuse et al.
LANCET (2007)
Poor efficacy of amphotericin B-based therapy in CNS aspergillosis
Stefan Schwartz et al.
MYCOSES (2007)
Surgical resection of persistent pulmonary fungus nodules and secondary prophylaxis are effective in preventing fungal relapse in patients receiving chemotherapy or bone marrow transplantation for leukemia
A. Nosari et al.
BONE MARROW TRANSPLANTATION (2007)
Liposomal amphotericin B (AmBisome®) efficacy in confirmed invasive aspergillosis and other filamentous fungal infections in immunocompromised hosts:: a pooled analysis
C. Cordonnier et al.
MYCOSES (2007)
Monitoring plasma voriconazole levels may be necessary to avoid subtherapeutic levels in hematopoietic stem cell transplant recipients
Steve Trifilio et al.
CANCER (2007)
Scedosporium prolificans brain abscess in a patient with chronic granulomatous disease: Successful combination therapy with vorieonazole and terbinafine
Sunil V. Bhat et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2007)
Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: An externally controlled trial
Thomas J. Walsh et al.
CLINICAL INFECTIOUS DISEASES (2007)
Variability of voriconazole plasma levels measured by new high-performance liquid chromatography and bioassay methods
Andres Pascual et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Granulocyte transfusion: Current status
Thomas H. Price
SEMINARS IN HEMATOLOGY (2007)
CNS aspergillosis - Recognition, diagnosis and management
Markus Ruhnke et al.
CNS DRUGS (2007)
Treatment of invasive pulmonary aspergillosis in neutropenic patients by additional Bronchoscopic amphotericin B instillation
J. Winkler et al.
RESPIRATION (2007)
Caspofungin as salvage monotherapy for invasive aspergillosis in patients with haematological malignancies or following allogeneic stem cell transplantation: efficacy and concomitant cyclosporin A
C. O. Morrissey et al.
MYCOSES (2007)
Multicenter, noncomparative study of caspofungin in combination with other antifungals as salvage therapy in adults with invasive aspergillosis
Johan Maertens et al.
CANCER (2006)
Scedosporium infection in a tertiary care cancer center:: A review of 25 cases from 1989-2006
Gregory A. Lamaris et al.
CLINICAL INFECTIOUS DISEASES (2006)
Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis
David W. Denning et al.
JOURNAL OF INFECTION (2006)
Defining clinical failure for salvage studies
Georg Maschmeyer et al.
MEDICAL MYCOLOGY (2006)
Prospective study of amphotericin B formulations in immunocompromised patients in 4 European countries
Andrew J. Ullmann et al.
CLINICAL INFECTIOUS DISEASES (2006)
Successful treatment of breakthrough Trichosporon asahii fungemia with voriconazole in a patient with acute myeloid leukemia
Noboru Asada et al.
CLINICAL INFECTIOUS DISEASES (2006)
Treatment of solid organ transplant patients with invasive fungal infections:: should a combination of antifungal drugs be used?
Patricia Munoz et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2006)
Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: A multi-institutional study
Kevin W. Garey et al.
CLINICAL INFECTIOUS DISEASES (2006)
Safety of long-term oral posaconazole use in the treatment of refractory invasive fungal infections
Issam I. Raad et al.
CLINICAL INFECTIOUS DISEASES (2006)
Posaconazole as salvage treatment for invasive fusariosis in patients with underlying hematologic malignancy and other conditions
II Raad et al.
CLINICAL INFECTIOUS DISEASES (2006)
Effect of a nutritional supplement on posaconazole pharmacokinetics following oral administration to healthy volunteers
A Sansone-Parsons et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Posaconazole is effective as salvage therapy in zygomycosis: A retrospective summary of 91 cases
JAH van Burik et al.
CLINICAL INFECTIOUS DISEASES (2006)
Epidemiology of Candida albicans infections and role of non-Candida-albicans yeasts
M Ruhnke
CURRENT DRUG TARGETS (2006)
Breakthrough trichosporonosis in patients with hematologic malignancies receiving micafungin
K Matsue et al.
CLINICAL INFECTIOUS DISEASES (2006)
A bedside scoring system (Candida score'') for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization
C León et al.
CRITICAL CARE MEDICINE (2006)
Pharmacokinetics, safety, and efficacy of posaconazole in patients with persistent febrile neutropenia or refractory invasive fungal infection
AJ Ullmann et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Caspofungin treatment in severely ill, immunocompromised patients: a case-documentation study of 118 patients
A Glasmacher et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation
K Perruccio et al.
BLOOD (2005)
Prophylactic and interventional granulocyte transfusions in patients with haematological malignancies and life-threatening infections during neutropenia
S Mousset et al.
ANNALS OF HEMATOLOGY (2005)
Effectiveness of amphotericin B lipid complex (ABLC) treatment in allogeneic hematopoietic cell transplant (HCT) recipients with invasive aspergillosis (IA)
JI Ito et al.
BONE MARROW TRANSPLANTATION (2005)
Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial
BJ Kullberg et al.
LANCET (2005)
Improved outcome in central nervous system aspergillosis, using voriconazole treatment
S Schwartz et al.
BLOOD (2005)
Epidemiology and outcome of infections due to Aspergillus terreus:: 10-year single centre experience
C Lass-Flörl et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Bloodstream infections due to Candida species in the intensive care unit:: Identifying especially high-risk patients to determine prevention strategies
RP Wenzel et al.
CLINICAL INFECTIOUS DISEASES (2005)
Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained:: a potential risk factor for hospital mortality
M Morrell et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer
G Chamilos et al.
CLINICAL INFECTIOUS DISEASES (2005)
Treatment of non-Aspergillus moulds in immunocompromised patients, with amphotericin B lipid complex
JR Perfect
CLINICAL INFECTIOUS DISEASES (2005)
Treatment of Candida infections with amphotericin B lipid complex
JI Ito et al.
CLINICAL INFECTIOUS DISEASES (2005)
Fungemia due to Trichosporon asahii in a neutropenic child refractory to amphotericin B -: Clearance with voriconazole
C Antachopoulos et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2005)
Amphotericin B lipid complex in the management of invasive aspergillosis in immunocompromised patients
PH Chandrasekar et al.
CLINICAL INFECTIOUS DISEASES (2005)
Disseminated Scedosporium prolificans infection and survival of a child with acute lymphoblastic leukemia
M Whyte et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2005)
Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies:: a retrospective multicenter study from Italy and review of the literature
C Girmenia et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Epidemiology and outcome of zygomycosis: A review of 929 reported cases
MM Roden et al.
CLINICAL INFECTIOUS DISEASES (2005)
Management of central venous catheters in patients with cancer and candidemia
I Raad et al.
CLINICAL INFECTIOUS DISEASES (2004)
Epidemiology of candidaemia in Europe: Results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study
AM Tortorano et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2004)
Lipid formulations of amphotericin B preserve and stabilize renal function in HSCT recipients
CB Miller et al.
BONE MARROW TRANSPLANTATION (2004)
Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants
FM Marty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Identification of human UDP-glucuronosyltransferase enzyme(s) responsible for the glucuronidation of posaconazole (Noxafil)
A Ghosal et al.
DRUG METABOLISM AND DISPOSITION (2004)
Aspergillus terreus - An emerging amphotericin B-resistant opportunistic mold in patients with Hematologic malignancies
RY Hachem et al.
CANCER (2004)
Combination antifungal therapy for invasive aspergillosis
KA Marr et al.
CLINICAL INFECTIOUS DISEASES (2004)
Trichosporon asahii infection treated with caspofungin combined with liposomal amphotericin B
M Bassetti et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Impact of high-dose granulocyte transfusions in patients with cancer with candidemia - Retrospective case-control analysis of 491 episodes of candida species bloodstream infections
A Safdar et al.
CANCER (2004)
Candida endocarditis:: Contemporary cases from the international collaboration of infectious endocarditis merged database (ICE-MD)
DK Benjamin et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2004)
Predicting outcome after lung resection for invasive pulmonary aspergillosis in patients with neutropenia
P Matt et al.
CHEST (2004)
Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy
J Maertens et al.
CLINICAL INFECTIOUS DISEASES (2004)
Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial
AE Brouwer et al.
LANCET (2004)
Fusarium infection in hematopoietic stem cell transplant recipients
M Nucci et al.
CLINICAL INFECTIOUS DISEASES (2004)
Combination chemotherapy for invasive fungal infections: what laboratory and clinical studies tell us so far
DP Kontoyiannis et al.
DRUG RESISTANCE UPDATES (2003)
Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection
M Nucci et al.
CANCER (2003)
A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects
JH Rex et al.
CLINICAL INFECTIOUS DISEASES (2003)
Voriconazole treatment for less-common, emerging, or refractory fungal infections
JR Perfect et al.
CLINICAL INFECTIOUS DISEASES (2003)
Clinical pharmacology of antifungal compounds
AH Groll et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2003)
Multidrug-resistant Trichosporon asahii isolates are susceptible to voriconazole
R Falk et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2003)
Comparison of caspofungin and amphotericin B for invasive candidiasis.
J Mora-Duarte et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Granulocyte transfusion therapy for infections in candidates and recipients of HPC transplantation:: a comparative analysis of feasibility and outcome for community donors versus related donors
K Hübel et al.
TRANSFUSION (2002)
Breakthrough candidemia, in patients with cancer differs from de novo candidemia in host factors and Candida species but not intensity
DP Kontoyiannis et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2002)
Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis
R Herbrecht et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Breakthrough trichosporonosis in a bone marrow transplant recipient receiving caspofungin acetate
D Goodman et al.
CLINICAL INFECTIOUS DISEASES (2002)
Infective endocarditis in intravenous drug abusers and HIV-1 infected patients
JM Miró et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2002)
Antifungal susceptibility of Candida biofilms:: Unique efficacy of amphotericin B lipid formulations and echinocandins
DM Kuhn et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Interaction of common azole antifungals with P glycoprotein
EJ Wang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus
S Ascioglu et al.
CLINICAL INFECTIOUS DISEASES (2002)
Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis
DW Denning et al.
CLINICAL INFECTIOUS DISEASES (2002)
The epidemiology of nephrotoxicity associated with conventional amphotericin B therapy
S Harbarth et al.
AMERICAN JOURNAL OF MEDICINE (2001)
Scedosporium infection in immunocompromised patients:: Successful use of liposomal amphotericin B and itraconazole
D Barbaric et al.
MEDICAL AND PEDIATRIC ONCOLOGY (2001)
Risk factors for candidal bloodstream infections in surgical intensive care unit patients: The NEMIS Prospective Multicenter Study
HM Blumberg et al.
CLINICAL INFECTIOUS DISEASES (2001)
Mortality and costs of acute renal failure associated with amphotericin B therapy
DW Bates et al.
CLINICAL INFECTIOUS DISEASES (2001)
Aspergillosis case - Fatality rate: Systematic review of the literature
SJ Lin et al.
CLINICAL INFECTIOUS DISEASES (2001)
Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system
AH Groll et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
分享论文
